
About Celestia
Celestia is a Technology company based in Vaduz (Liechtenstein) founded in 2011 by Nick White, John Adler, and Ismail Khoffi. It operates as a blockchain-based modular consensus and data network. Celestia has raised $204.36 million across 10 funding rounds from investors including FTX, Galaxy and OKX. The company has 1 employees. Celestia has completed 1 acquisition, including Sovereign. Its website celestia.org draws about 53 thousand monthly visits. Its Indian entity Celestial Biolabs Limited reported revenue of βΉ16.9 Lakh. Its focus areas include High Tech, Blockchain Infrastructure, Blockchain Network and Blockchain Technology. Its competitors include Binance, Solana, Chain, Ankr and Mysten Labs and 1 more; 6 of its 6 listed competitors have raised funding.
Company details
Celestia was founded in 2011 and is headquartered in Vaduz, Liechtenstein. Operations focus on the blockchain sector, where a pluggable consensus and data availability layer is offered to support the deployment of decentralized blockchains. The technology stack is modularized by separating consensus from application execution, enabling customized blockchain solutions. Core services include data availability sampling and light node verification for scalable networks.
- Headquarters Vaduz, Liechtenstein
- Employees 1
- Founders Nick White, John Adler, Ismail Khoffi
- SectorsTechnology
- Website category Finance · Investing
- Emailβ’β’β’β’β’β’β’β’
- Website celestia.org
- Social LinkedIn X
- Legal Name Celestial Labs Ltd
- Date of Incorporation 19 Nov, 1997
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹16.9 Lakh
FY 2023 · +14% YoY
- Net Loss-₹57.2 Lakh
FY 2023 · -339% margin
- EBITDA-₹54.4 Lakh
FY 2023 · -322% margin
- Total Equity Funding$204.36M (USD)
in 10 rounds
- Latest Funding Round$100M (USD), Series C
Sep 2024
- InvestorsFTX
& 34 more
- Employee Count1
- Investments & Acquisitions
Associated legal entities of Celestia
Celestia operates through Celestial Biolabs Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celestial Biolabs Limited Listed CIN L72200TG1997PLC028374 | Active | 19 Nov 1997 | Hyderabad, Telangana | ₹0.2 Cr | 1 | 6 | View details |
Funding Insights of Celestia
Celestia has successfully raised a total of $204.36M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $204.36M
- Total Rounds 10
- Last Round Series C β $100M
- Investors Count 35
All 10 funding rounds of Celestia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $100M | Series C | β | Bain Capital Crypto, Syncracy | β |
| Oct 2023 | – | Series B | β | OKX | β |
| Oct 2022 | $55M | Series A | β | Bain Capital Crypto, Polychain | |
| Mar 2021 | $1.5M | Seed | β | Maven 11, Interchain | |
| Oct 2019 | $10.51M | Seed | β | β | β |
| Apr 2019 | $3M | Seed | β | β | β |
| Jan 2018 | $6.85M | Seed | β | β | β |
| Feb 2017 | $5M | Seed | β | β | β |
| Aug 2015 | $22.5M | Seed | β | β | β |
| Jun 2015 | – | Seed | β | Max Ventures | β |
35 investors in total: 28 institutional and 7 angel.
Investors in Celestia
Celestia has secured backing from 35 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include FTX, Galaxy and OKX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ICO-based venture capital fund | – | 1kx.network | - | |
Robot Ventures is associated with technology or robotics. | – | robvc.com | New York, United States | |
Investments are directed toward decentralized information networks by Placeholder. | 2017 | placeholder.vc | New York, United States | |
Venture capital firm investing in the blockchain sector | – | blockchain.capital | San Francisco, United States | |
Venture capital firm offering funding and tools for startups in technology and investment sectors. | – | nfx.com | - | |
Venture capital is provided to tech startups by Maven 11. | – | maven11.com | Amsterdam, Netherlands | |
Advisory, venture capital, and startup services for blockchain are provided. | – | spartangroup.io | Singapore, Singapore | |
Venture capital investments are directed toward web3 sectors. | – | figmentcapital.io | New York, United States | |
Signature Ventures is involved in backing innovative ventures. | – | signatureventures.com | - | |
Investments in cryptocurrencies are managed by Divergence Ventures. | – | div.vc | San Francisco, United States |
Investor details for Celestia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Celestial Biolabs Limited (Celestia)
Celestial Biolabs Limited is the primary company behind Celestia. The board of Celestial Biolabs Limited currently have 5 directors; the longest-serving is Padma Singh, appointed in 2005. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Padma Singh DIN 01448915 | Director | 30 Sep 2005 | 21 yrs | Celestial Biolabs Limited |
| Amit Kumar Singh DIN 01824426 | Managing Director | 28 Sep 2017 | 9 yrs | Celestial Biolabs Limited |
| Rakle Mathur Nath DIN 00589621 | Director | 02 Sep 2022 | 4 yrs 1 mo | Celestial Biolabs Limited |
| Durga Narasimha Kumar Gangadharuni DIN 00661401 | Director | 02 Sep 2022 | 4 yrs 1 mo | Celestial Biolabs Limited |
| Prabhakar Korada DIN 09717775 | Director | 02 Sep 2022 | 4 yrs 1 mo | Celestial Biolabs Limited |
People of Celestia
25 people are tracked at Celestia (8 in leadership, 6 in board & advisors, 11 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Nick White | Co-Founder | Leadership |
John Adler | Co-Founder | Leadership |
Ismail Khoffi | Co-Founder | Leadership |
Ekram Ahmed | Head of Marketing & Communications | Leadership |
Mustafa Al-Bassam | CEO | Leadership |
Elissa Greenfield | Head of People Ops | Leadership |
Nhu Viet Nguyen | Head Of Devrel | Leadership |
Sarah Armstrong | Chief Financial Officer | Leadership |
Morgan Beller | Advisor | Board & advisors |
Marko Baricevic | Advisor | Board & advisors |
George Danezis | Advisor | Board & advisors |
Zaki Manian | Advisor | Board & advisors |
James Prestwich | Advisor | Board & advisors |
Ethan Buchman | Advisor | Board & advisors |
Nina Barbakadze | Distributed Systems Engineer | Team |
Javed Khan | Software Engineer | Team |
Natalie Kubalova | DevRel Program Manager | Team |
Amy Yu | Operations Manager | Team |
Rachid Chami | Software Engineer | Team |
Tejinder Nijjer | Operations Associate | Team |
5 more people are available in the full profile.
Complete people profiles for Celestia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Celestia
Figures of Celestial Biolabs Limited, the primary company behind Celestia, for FY 2023. Revenue was ₹16.9 Lakh (+14% year on year). Net loss was -₹57.2 Lakh (-339% margin). EBITDA was -₹54.4 Lakh (-322% margin). Revenue has grown at a compounded annual rate of -68% over three years and -67% over five years.
- ₹16.9 LakhRevenue · FY 2023 · +14% YoY
- -₹57.2 LakhNet loss · -339% margin
- -₹54.4 LakhEBITDA · -322% margin
- ₹22.59 CrPaid-up capital
- 1Employees (provident fund records)
- -68%Revenue CAGR, 3 years
- -67%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Celestial Biolabs Limited are on its company page.
Detailed financial statements for Celestia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celestia
Celestia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sovereign.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Interoperable and scalable rollups are provided for any blockchain. | sovereign.xyz | New York, United States | 2022 | Jul 2026 | β’β’β’β’ |
Complete acquisition details for Celestia
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Celestia
4 dated milestones of Celestia across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Celestia is founded.
- Funding First funding round.
- Funding Latest funding round, Series C, of $100.0M.
- Acquisition Acquires Sovereign.
Competitors of Celestia
Celestia has 6 listed competitors in our database, 6 of them funded. They include Binance, Solana, Chain, Ankr and Mysten Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| binance.com | 2017 | Ta Xbiex, Malta | $2.02B | – | Online exchange platform for cryptocurrency | |
| solana.com | 2010 | San Francisco, United States | $374.15M | 62 | Blockchain infrastructure for transactions and counting is provided by Solana. | |
| chain.com | 2014 | San Francisco, United States | $39.5M | – | Blockchain infrastructure is offered for financial application development. | |
| ankr.com | 2017 | San Francisco, United States | $16M | 4 | Web3-native infrastructure for blockchain development and decentralization is provided. | |
| mystenlabs.com | 2021 | Palo Alto, United States | $336M | – | Web3 infrastructure solutions are offered via a blockchain platform. | |
| o1labs.org | 2017 | San Francisco, United States | $29.4M | 21 | Provider of a blockchain network |
Detailed competitors of Celestia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Celestia
The website of Celestia (celestia.org) receives about 53.1K visits a month and ranks #570,898 among all websites worldwide, #5,680 in Investing.
- Monthly visits53.1K
▼ 8.2% vs previous month
- Unique visitors25K
per month
- Global rank#570,898
among all websites
- Category rank#5,680
Finance · Investing
- Bounce rate38%
- Pages per visit2.1
- Average visit33 sec
- DevicesDesktop 31% Β· Mobile 69%
Websites whose visitors overlap most with Celestia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eclipse.xyz | 100% | 6.2K | #3,358,972 | View details | |
| kaleido.io | 93% | 71K | #484,726 | View details | |
| xord.com | 93% | 2.5K | #6,779,733 | View details | |
| chainalysis.com | 93% | 268.8K | #109,044 | View details | |
| solana.org | 93% | – | #567,256 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for Celestia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Blockchain & Decentralized Infrastructure
10 companies that operate in the same segment as Celestia (Blockchain & Decentralized Infrastructure), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Terraform Labs is engaged in blockchain technology development. | 2018 | Singapore, Singapore | USD 57 M | – | – | |
Ledger is recognized for providing secure cryptocurrency hardware wallets. | 2014 | Paris, France | USD 575.4 M | – | – | |
Decentralized exchange platform for cryptocurrency trading is operated. | 2018 | New York, New York, United States | USD 176 M | – | 85 | |
Developer of blockchain and web3 software platform | 2014 | Fort Worth, Texas, United States | USD 725 M | – | – | |
Public blockchain network platform | 2017 | Zug, Zug, Switzerland | USD 542.29 M | – | – | |
Scalable blockchain interoperability protocols are developed for enhanced network security. | 2017 | George Town, Cayman Islands | USD 450.75 M | – | – | |
Blockchain-based PC and mobile games are developed and published. | 2006 | Kowloon, Hong Kong, China | USD 973.19 M | – | – | |
Protocols for blockchain-based solutions are provided by Aptos. | 2021 | Palo Alto, California, United States | USD 350 M | – | – | |
Cloud-based blockchain platform for application development is provided. | 2013 | San Francisco, California, United States | USD 597.81 M | – | – | |
Blockchain-based fantasy sports marketplace is provided for multiple sports. | 2018 | Saint-mande, Val-de-marne, France | USD 738.84 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Celestia
Complete news archive for Celestia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celestia
Celestia was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Celestia is headquartered in Vaduz, Liechtenstein.
Celestia is a funded company, having raised a total of $204.36M across 10 funding rounds to date.
Celestia has 1 employees.
The primary company behind Celestia, Celestial Biolabs Limited, reported revenue of βΉ16.9 Lakh for FY 2023, up 14% year on year.
Celestia was founded in 2011 and is headquartered in Vaduz, Liechtenstein. Operations focus on the blockchain sector, where a pluggable consensus and data availability layer is offered to support the deployment of decentralized blockchains. The technology stack is modularized by separating consensus from application execution, enabling customized blockchain solutions. Core services include data availability sampling and light node verification for scalable networks.
Celestia's top competitors include Binance, Mysten Labs and Solana.
Celestia has made 1 acquisition, including Sovereign.
Celestia has 35 investors. Key investors include FTX, Galaxy, OKX, Protocol Labs, and Delphi Digital.
Celestia operates through Celestial Biolabs Limited.
The legal entities of Celestia currently have 6 directors, including Rakle Mathur Nath, Durga Narasimha Kumar Gangadharuni, Prabhakar Korada and others.
